Siglec-1/CD169 Antibody (908102) [Janelia Fluor® 525]
Novus Biologicals, part of Bio-Techne | Catalog # FAB5197JF525
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 525
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 908102
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Siglec-1/CD169
Ser20-Gln1641
Accession # Q9BZZ2
Ser20-Gln1641
Accession # Q9BZZ2
Specificity
Detects human Siglec-1/CD169 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Siglec-1/CD169 Antibody (908102) [Janelia Fluor® 525]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Siglec-1/CD169
Long Name
Sialic Acid Binding Ig-like Lectin 1
Alternate Names
CD169, Siglec1
Gene Symbol
SIGLEC1
Additional Siglec-1/CD169 Products
Product Documents for Siglec-1/CD169 Antibody (908102) [Janelia Fluor® 525]
Product Specific Notices for Siglec-1/CD169 Antibody (908102) [Janelia Fluor® 525]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...